07:00 , Jul 26, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Mucopolysaccharidosis (MPS) Arylsulfatase G (ARSG) Mouse and in vitro studies suggest restoring ARSG levels could be useful for treating MPS type IIIE, a lysosomal...